Heart transplantation in adults with end-stage congenital heart disease

Luke J Burchill1, Heather J Ross

  • 1University of Toronto, Toronto Congenital Cardiac Centre for Adults, Peter Munk Cardiac Centre, University Health Network, Canada.

Future Cardiology
|March 15, 2012
PubMed

Insights

Adults with congenital heart disease face heart failure risks. Heart transplantation offers long-term survival but carries higher early mortality risks for these patients.

Area of Science:

  • Cardiology
  • Adult Congenital Heart Disease
  • Heart Failure Management

Background:

  • Adult congenital heart disease (ACHD) survivors often have residual cardiac abnormalities.
  • These abnormalities increase the risk of late-onset heart failure and related complications.
  • Managing ACHD requires integrated care from adult congenital and heart failure specialists.

Purpose of the Study:

  • To evaluate the complexities of managing heart failure in adults with congenital heart disease.
  • To discuss the critical considerations for heart transplantation in this unique patient population.
  • To analyze the risks and benefits of heart transplantation for ACHD patients.

Main Methods:

  • Review of clinical management strategies for ACHD patients with heart failure.
  • Assessment of heart transplant eligibility criteria and outcomes in ACHD.
  • Analysis of post-transplantation complications and survival rates in ACHD.

Main Results:

  • ACHD patients are prone to heart failure due to structural and functional cardiac residuals.
  • Heart transplantation decisions involve balancing listing risks against disease progression and mortality.
  • Post-transplant outcomes in ACHD are complicated by higher risks of bleeding, infection, and donor right heart failure.

Conclusions:

  • Effective management of ACHD necessitates collaboration between specialists.
  • Heart transplantation presents a trade-off between early mortality risks and long-term survival benefits for ACHD patients.
  • Long-term survival post-transplantation is achievable for ACHD patients who survive the initial year.